TickerFacts.

Eloxx Pharmaceuticals, Inc. (ELOX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$31.91M
Year ended 2022-12-31
2010-06-30: -$4.74M2011-06-30: -$5.39M2012-06-30: -$4.39M2013-06-30: -$3.90M2014-06-30: -$4.87M2015-12-31: -$5.75M2016-12-31: -$8.88M2017-12-31: -$16.17M2018-12-31: -$31.60M2019-12-31: -$39.43M2021-12-31: -$35.09M2022-12-31: -$31.91M-$31.91M
2010-06-30 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$31.91Mn/m2023-03-31, From 2022-01-01
2021-12-31-$35.09Mn/a2023-03-31, From 2021-01-01
No annual figure between 2019-12-31 and 2021-12-31.
2019-12-31-$39.43Mn/m2022-03-30, From 2019-01-01
2018-12-31-$31.60Mn/m2021-03-12, From 2018-01-01
2017-12-31-$16.17Mn/m2020-03-06, From 2017-01-01
2016-12-31-$8.88Mn/m2019-03-14, From 2016-01-01
2015-12-31-$5.75Mn/a2018-03-16, From 2015-01-01
No annual figure between 2014-06-30 and 2015-12-31.
2014-06-30-$4.87Mn/m2016-10-13, From 2013-07-01
2013-06-30-$3.90Mn/m2015-10-09, From 2012-07-01
2012-06-30-$4.39Mn/m2014-09-29, From 2011-07-01
2011-06-30-$5.39Mn/m2013-09-11, From 2010-07-01
2010-06-30-$4.74Mn/a2012-10-26, From 2009-07-01